Search Results - "Foster, R. N."

Prophylactic cranial irradiation in small-cell lung cancer: Findings from a North Central Cancer Treatment Group Pooled Analysis by Schild, S.E., Foster, N.R., Meyers, J.P., Ross, H.J., Stella, P.J., Garces, Y.I., Olivier, K.R., Molina, J.R., Past, L.R., Adjei, A.A.

“…This pooled analysis evaluated the outcomes of prophylactic cranial irradiation (PCI) in 739 small-cell lung cancer (SCLC patients with stable disease (SD) or…”
Get full text

Prognostic effect of activated EGFR expression in human colon carcinomas: comparison with EGFR status by Rego, R L, Foster, N R, Smyrk, T C, Le, M, O'Connell, M J, Sargent, D J, Windschitl, H, Sinicrope, F A

“…Background: Evidence suggests that epidermal growth factor receptor (EGFR)-activation status may better predict the clinical behaviour of colon cancers than…”
Get full text

Micronization by Rapid Expansion of Supercritical Solutions to Enhance the Dissolution Rates of Poorly Water-Soluble Pharmaceuticals by Charoenchaitrakool, M, Dehghani, F, Foster, N. R, Chan, H. K

“…The dissolution of a drug into the biological environment can be enhanced by reducing the particle size of the drug. In this study the rapid expansion of…”
Get full text

Utilization of supercritical carbon dioxide for complex formation of ibuprofen and methyl-β-cyclodextrin by Charoenchaitrakool, M., Dehghani, F., Foster, N.R.

“…The dissolution rate of a drug into the biological environment can be enhanced by forming complexes with cyclodextrins and their derivatives. In this study,…”
Get full text

Multicenter phase II study of the AKT inhibitor MK-2206 in recurrent or metastatic nasopharyngeal carcinoma from patients in the mayo phase II consortium and the cancer therapeutics research group (MC1079) by Ma, B. B. Y., Goh, B. C., Lim, W. T., Hui, E. P., Tan, E. H., Lopes, G. de Lima, Lo, K. W., Li, L., Loong, H., Foster, N. R., Erlichman, C., King, A. D., Kam, M. K. M., Leung, S. F., Chan, K. C., Chan, A. T. C.

“…Summary Background This study investigated the activity of MK-2206, an AKT inhibitor, in metastatic or recurrent nasopharyngeal carcinoma (NPC). Method Oral…”
Get full text

Active absorption of electromagnetic pulses in a cavity by Horsley, S A R, Foster, R N, Tyc, T, Philbin, T G

“…We show that a pulse of electromagnetic radiation launched into a cavity can be completely absorbed into an infinitesimal region of space, provided one has a…”
Get full text

A review of subcritical water as a solvent and its utilisation for the processing of hydrophobic organic compounds by Carr, Adam G., Mammucari, Raffaella, Foster, N.R.

“…► Subcritical water is a tuneable solvent due to the sensitivity of the dielectric constant with changes in temperature ► Effect of solute structure on…”
Get full text

PS-341 and gemcitabine in patients with metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group (NCCTG) randomized phase II study by Alberts, S. R., Foster, N. R., Morton, R. F., Kugler, J., Schaefer, P., Wiesenfeld, M., Fitch, T. R., Steen, P., Kim, G. P., Gill, S.

“…Background: PS-341 is a proteasome inhibitor with preclinical activity in pancreatic cancer tumor models and synergistic activity with gemcitabine. This…”
Get full text

Oxaliplatin and capecitabine in patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction and gastric cardia: a phase II study from the North Central Cancer Treatment Group by Jatoi, A., Murphy, B. R., Foster, N. R., Nikcevich, D. A., Alberts, S. R., Knost, J. A., Fitch, T. R., Rowland, K. M.

“…Purpose: The synergic combination of oxaliplatin and capecitabine has demonstrated activity against various gastrointestinal cancers, including colon cancer…”
Get full text

Caesarean section in a complicated case of central core disease by Foster, R. N., Boothroyd, K. P.

“…Summary We describe the anaesthetic management of a 21‐year‐old lady with central core disease for elective Caesarean section. Central core disease is…”
Get full text

Analysis of tumor microenvironmental features to refine prognosis by T, N risk group in patients with stage III colon cancer (NCCTG N0147) (Alliance) by Lee, H., Sha, D., Foster, N.R., Shi, Q., Alberts, S.R., Smyrk, T.C., Sinicrope, F.A.

“…Tumor-infiltrating lymphocytes (TILs), tumor budding, and micropapillary architecture may influence tumor growth and metastatic potential, thereby enhancing…”
Get full text

DNA Mismatch Repair Status and Colon Cancer Recurrence and Survival in Clinical Trials of 5-Fluorouracil-Based Adjuvant Therapy by SINICROPE, Frank A, FOSTER, Nathan R, SARGENT, Daniel J, THIBODEAU, Stephen N, MARSONI, Silvia, MONGES, Genevieve, LABIANCA, Roberto, YOTHERS, Greg, ALLEGRA, Carmen, MOORE, Malcolm J, GALLINGER, Steven

“…Approximately 15% of colorectal cancers develop because of defective function of the DNA mismatch repair (MMR) system. We determined the association of MMR…”
Get full text

Association of tumor-infiltrating lymphocytes with survival depends on primary tumor sidedness in stage III colon cancers (NCCTG N0147) [Alliance] by Saberzadeh-Ardestani, B., Foster, N.R., Lee, H.E., Shi, Q., Alberts, S.R., Smyrk, T.C., Sinicrope, F.A.

“…Tumor-infiltrating lymphocytes (TILs) are a robust and independent prognostic variable in localized colon cancer. Given reported differences in molecular…”
Get full text

Gene expression profiling identifies responsive patients with cancer of unknown primary treated with carboplatin, paclitaxel, and everolimus: NCCTG N0871 (alliance) by Yoon, H.H., Foster, N.R., Meyers, J.P., Steen, P.D., Visscher, D.W., Pillai, R., Prow, D.M., Reynolds, C.M., Marchello, B.T., Mowat, R.B., Mattar, B.I., Erlichman, C., Goetz, M.P.

“…Carboplatin (C) and paclitaxel (P) are standard treatments for carcinoma of unknown primary (CUP). Everolimus, an mTOR inhibitor, exhibits activity in diverse…”
Get full text

Particle Production of Steroid Drugs Using Supercritical Fluid Processing by Alessi, P, Cortesi, A, Kikic, I, Foster, N. R, Macnaughton, S. J, Colombo, I

“…The manufacture of fine particles of two steroid drugsprogesterone and medroxyprogesterone acetatehas been investigated through the rapid expansion of…”
Get full text

The influence of operating conditions on the dense gas precipitation of model proteins by Thiering, Russell, Dehghani, Fariba, Dillow, Angela, Foster, Neil R

“…Dense gas techniques provide a suite of clean technology options for the processing of pharmaceuticals. Monodisperse, micron‐sized particles can be produced at…”
Get full text

Another problem with adhesive drapes by Foster, R. N., Scotson, I.

Get full text

Synthesis, Purification, and Micronization of Pharmaceuticals Using the Gas Antisolvent Technique by Warwick, B, Dehghani, F, Foster, N. R, Biffin, J. R, Regtop, H. L

“…The synthesis, purification, and micronization of the nonsteroidal antiinflammatory [Cu2(indomethacin)4L2] [Cu−Indo]; indomethacin =…”
Get full text

Transparent flexible ZnO/MWCNTs/PBMA ternary nanocomposite film with enhanced mechanical properties by Han, Xingwei, Zeng, Xiaofei, Wang, Jiexin, Kong, Dejia, Foster, N. R., Chen, Jianfeng

“…Functional organic-inorganic nanocomposites with high transparency show significant potential application in many fields. However, it is still a great…”
Get full text

Dense Gas Processing of Polymers by Yoganathan, R. B., Mammucari, R., Foster, N. R.

“…There is a growing global awareness about environmental pollution, and many sanctions and sustainable practices have been implemented. In particular, the use…”
Get full text